Dr Martin Kaiser, hematologist at the Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom, summarised for MPE the results of the OPTIMUM/MUKnine clinical trial ultra-risk myeloma patients.
Негізгі бет ASH 2023 | High-risk myeloma
Dr Martin Kaiser, hematologist at the Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom, summarised for MPE the results of the OPTIMUM/MUKnine clinical trial ultra-risk myeloma patients.
Пікірлер